American Financial Group insider files Rule 144 to sell 920 shares

Rhea-AI Filing Summary

Form 144 filing for American Financial Group, Inc. (AFG) discloses a proposed sale under Rule 144 of 920 shares of the company's common stock, with an aggregate market value of $125,920.40. The shares are to be sold through UBS Financial Services on the NYSE and are scheduled for 09/03/2025. The securities were acquired as director compensation on 06/03/2024 (1,279 shares acquired on that date), and payment was recorded as director compensation. The filer reports no securities sold in the past three months. The filing includes the standard representation that the selling person is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider notice of intended sale: 920 shares slated for sale via UBS on the NYSE; sourced from director compensation.

The filing presents a straightforward Rule 144 notice without earnings or operational data. The size of the proposed sale ($125,920.40) is small relative to the company's outstanding shares (83,394,479 reported), suggesting limited market impact. No prior three-month sales are reported, and acquisition details tie the shares to director compensation on 06/03/2024, which is consistent with an executive or director selling vested compensation. The filing contains the required attestation regarding material non-public information.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure: a director-derived holding is scheduled for sale under Rule 144, with appropriate broker and schedule details.

The notice includes essential compliance elements: broker identity (UBS Financial Services), intended sale date (09/03/2025), and the provenance of shares (director compensation). The absence of reported sales in the prior three months implies this is not part of a pattern of frequent insider disposals. The representation that the seller is unaware of undisclosed material adverse information is standard and necessary for Rule 144 filings.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	FTB Financial Services UBS Financial Services Inc. 8044 Montgomery Road Suite 100W Cincinnati OH 45236	920	125920.40	83394479	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/03/2024	Director Compensation	Issuer			1279	06/03/2024	Director Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AFG Form 144 disclose?

The filing discloses a proposed sale of 920 shares of AFG common stock valued at $125,920.40, to be sold through UBS on the NYSE on 09/03/2025.

Who acquired the shares and how were they acquired?

The shares were acquired on 06/03/2024 as director compensation, with 1,279 shares noted as acquired on that date.

Has the filer sold AFG securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Which broker will handle the sale listed in the Form 144?

The sale is to be handled by UBS Financial Services Inc., located in Cincinnati, Ohio.

Does the Form 144 include a statement about material non-public information?

Yes, the filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.